As per the terms of the agreement, Sun Pharma will have the exclusive worldwide rights for commercialising Fibromun. Previous Post Ashish Kacholia, Mukul Agarwal-backed Vikran Engineering files DRHP with SEBI for ₹1,000 cr IPO Next Post Escorts Kubota sells 2.5% more tractors in Sept, exports decline by over 45% Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email, and website in this browser for the next time I comment.Post Comment